Creating new treatments for asthma
Official title: Development of Novel Therapeutics for Asthma
Funded at Biotherapeutics, INC. · NIH-11008453 · Data updated 2026-11-12
This study is looking for new and better treatments for asthma that are safer and more effective, using advanced computer models and experiments to understand how certain immune cells and metabolism affect the condition.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Biotherapeutics, INC. NIH-funded |
| Lab location | 1 site (Blacksburg, United States) |
| Project start | August 20, 2024 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $288,986 |
| NIH project number | 1R43HL176386-01 |
| Project ID | NIH-11008453 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals with asthma, particularly those who have not responded well to existing therapies.
✕Less likely to help
Patients with mild asthma who are well-controlled on current therapies may not benefit from this research.
What this research studies
This research focuses on developing innovative therapeutics for asthma by utilizing advanced computational modeling and experimental techniques. The goal is to create precision medicine solutions that address the limitations of current asthma treatments, which often have inadequate efficacy and significant side effects. By exploring the role of regulatory T cells and metabolic factors in asthma, the research aims to identify safer and more effective options for patients suffering from this chronic condition.
Why it matters
Potential benefit: If successful, this research could lead to the development of safer and more effective asthma treatments, improving the quality of life for patients.
How similar studies have gone: While there have been challenges in developing new asthma therapies, the innovative approach of targeting regulatory T cells and metabolic factors represents a novel direction that has not been extensively tested.
Where this research is happening
-
Biotherapeutics, INC.
Blacksburg, United States Active
Researchers
- Principal investigator: Bassaganya-Riera, Josep — Biotherapeutics, INC.
- Study coordinator: Bassaganya-Riera, Josep
Related research
Other NIH-funded projects on the same topics.
-
GLP-1 receptor agonists as immune targets to treat asthma in lean and obese adults
Aims to understand how GLP-1R‑agonist diabetes medicines may directly calm immune cells to reduce asthma in adults who are lean or obese.
-
Understanding how a type of immune cell called ILC2s affect asthma in adults
This grant studies how group 2 innate lymphoid cells influence asthma in adults to help identify new ways to manage airway inflammation.
-
Expanding understanding of asthma in kids through airways and blood profiling
A study at UC San Francisco will profile blood and nasal/sputum samples from 300 youth (including 200 with asthma) over a year to understand how environmental and social factors influence asthma in marginalized communities.
-
Preventing and improving asthma care for children in urban communities
This program will try several approaches — from giving helpful bacteria to babies to allergy immunotherapy and advanced airway testing — to prevent and better treat asthma in children who live in cities.
-
IDEAL project helps predict vaccine response, infections, and asthma in early childhood
A Child-focused program will collect and share saliva, blood, and tissue samples from diverse infants to find biological patterns that predict how vaccines work, how respiratory infections occur, and who develops asthma.
-
Understanding how early-life immune development affects vaccine responses and asthma risk in children
This project uses lab-grown human immune cells from infants and young children to explore why some kids respond poorly to vaccines and are more prone to respiratory infections and asthma.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.